Invasive pneumococcal disease in Indian adults: 11 years' experience

J Microbiol Immunol Infect. 2019 Oct;52(5):736-742. doi: 10.1016/j.jmii.2018.03.004. Epub 2018 May 22.

Abstract

Purpose: To investigate the epidemiology of invasive pneumococcal disease (IPD), prevalent serotypes, and pattern of antimicrobial resistance (AMR) in Indian adults.

Methods: Prospective laboratory based surveillance of IPD was carried out in >18 years age group between January 2007 and July 2017, from a tertiary care hospital in South India. All Streptococcus pneumoniae culture positives from blood, CSF and sterile body fluids were characterized to identify the serotypes and AMR.

Results: A total of 408 IPD cases were characterized in this study. The overall case fatality rate in this study was 17.8% (95% confidence interval (CI): 14.1, 22.4). Pneumonia (39%), meningitis (24.3%), and septicaemia (18.4%) were the most common clinical conditions associated with IPD. Serotypes 1, 3, 5, 19F, 8, 14, 23F, 4, 19A and 6B were the predominant serotypes in this study. Penicillin non-susceptibility was low with 6.4% CONCLUSION: Serotype data from this study helped in accurate estimation of pneumococcal conjugate vaccine-13 and pneumococcal polysaccharide vaccine-23 protective coverage against serotypes causing IPD in India as 58.7% (95% CI: 53.8, 63.4) and 67.4% (95% CI: 62.7, 71.8) respectively. Penicillin non-susceptibility in meningeal IPD cases is 27.4%. Empirical therapy for meningeal IPD must be cephalosporin in combination with vancomycin since cefotaxime non-susceptibility in meningeal IPD is 9.9.

Keywords: Adults; India; Invasive pneumococcal disease; Penicillin resistance; Vaccine coverage.

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Cefotaxime / therapeutic use
  • Cephalosporins / therapeutic use
  • Comorbidity
  • Drug Resistance, Bacterial
  • Epidemiological Monitoring
  • Female
  • Humans
  • India / epidemiology
  • Male
  • Meningitis / epidemiology
  • Microbial Sensitivity Tests
  • Middle Aged
  • Mortality
  • Penicillin Resistance
  • Penicillins / therapeutic use
  • Pneumococcal Infections / diagnosis
  • Pneumococcal Infections / epidemiology*
  • Pneumococcal Infections / microbiology*
  • Pneumococcal Infections / therapy
  • Pneumococcal Vaccines
  • Pneumonia / epidemiology
  • Prevalence
  • Prospective Studies
  • Serogroup*
  • Streptococcus pneumoniae / isolation & purification
  • Vaccines, Conjugate
  • Vancomycin / therapeutic use
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Penicillins
  • Pneumococcal Vaccines
  • Vaccines, Conjugate
  • Vancomycin
  • Cefotaxime